GeneDx Executive and Leadership Team

Bryan Dechairo, the Chief Operating Officer at GeneDx, directs all operational functions critical to the company's diagnostic testing services. Overseeing laboratory operations in Gaithersburg, Maryland, Dechairo ensures the efficient and accurate processing of whole exome sequencing, whole genome sequencing, and targeted gene panels. This leadership role involves optimizing workflows to manage GeneDx's extensive rare disease genomic dataset, a key asset powering clinical testing and research initiatives. Dechairo drives operational excellence, ensuring seamless integration between testing capabilities and the company's commitment to supporting drug discovery and health system research. By focusing on scalable infrastructure and rigorous quality control, Bryan Dechairo directly supports the company's mission to provide accessible genetic diagnostics to healthcare providers and hospitals across the United States and globally.

Rhonda Brandon, the Chief Information Officer at GeneDx, architects and executes the company's comprehensive information technology strategy. Brandon oversees the secure management and advancement of GeneDx's vast genomic datasets, including one of the world's largest rare disease genomic datasets. This critical function supports the company's advanced clinical testing capabilities and fuels vital drug discovery and health system research efforts. Brandon ensures robust data governance, cybersecurity protocols, and the technological infrastructure necessary for GeneDx's specialized genetic testing services, such as whole exome and whole genome sequencing. By driving innovation in data management and IT systems, Rhonda Brandon enables GeneDx to provide cutting-edge diagnostic solutions and maintain its leadership position in the genomic diagnostics sector, ensuring seamless access for healthcare providers and hospitals.

Linda Genen, the Chief Medical Officer at GeneDx, provides critical medical leadership and strategic direction for the company's diagnostic offerings. Genen guides the clinical interpretation and application of GeneDx's genetic testing services, including whole exome sequencing, whole genome sequencing, and targeted gene panels, ensuring their alignment with best medical practices. This role involves leveraging the company's extensive rare disease genomic dataset to enhance diagnostic accuracy and support healthcare providers in diagnosing inherited disorders. Linda Genen champions the integration of genetic counseling services and patient financial assistance programs, underscoring GeneDx's commitment to patient access and comprehensive care. By overseeing the medical validity and clinical utility of GeneDx's genomic solutions, Genen directly contributes to the company's mission of advancing patient outcomes through precise genetic diagnostics.

Heidi Chen, the Chief Legal Officer & Corporate Secretary at GeneDx, directs all legal affairs and corporate governance for the organization. Chen ensures compliance with complex regulatory frameworks governing genetic testing and healthcare data, particularly concerning rare disease genomic datasets and diagnostic services. This leadership position involves managing all legal aspects of GeneDx's operations, including intellectual property, contracts, and risk management, supporting the company's specialized offerings like whole exome and whole genome sequencing. Heidi Chen also oversees corporate secretarial duties, ensuring adherence to governance standards and facilitating effective communication with the board of directors. By providing expert legal counsel and strategic oversight, Chen safeguards GeneDx's operations and supports its mission to expand access to critical genetic diagnostics for healthcare providers and patients.